These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
120 related items for PubMed ID: 8635085
1. Prognostic value of preoperative immunosuppressive acidic protein in patients with gastric carcinoma. Findings from three independent clinical trials. Tumor Marker Committee for the Study Group of Immunochemotherapy with PSK for Gastric Cancer. Sakamoto J, Teramukai S, Koike A, Saji S, Ohashi Y, Nakazato H. Cancer; 1996 Jun 01; 77(11):2206-12. PubMed ID: 8635085 [Abstract] [Full Text] [Related]
2. Significance of postoperative adjuvant immunochemotherapy after curative resection of colorectal cancers: Association between host or tumor factors and survival. Munemoto Y, Iida Y, Abe J, Saito H, Fujisawa K, Kasahara Y, Mitsui T, Asada Y, Miura S. Int J Oncol; 2002 Feb 01; 20(2):403-11. PubMed ID: 11788909 [Abstract] [Full Text] [Related]
3. Prognostic value of preoperative immunosuppressive acidic protein levels in patients with gastric carcinoma. Takeuchi H, Maehara Y, Tokunaga E, Koga T, Kakeji Y, Sugimachi K. Hepatogastroenterology; 2003 Feb 01; 50(49):289-92. PubMed ID: 12630043 [Abstract] [Full Text] [Related]
7. Preoperative serum immunosuppressive acidic protein (IAP) test for the prognosis of gastric cancer: a statistical study of the threshold level and evaluation of the effect of the biological response modifier PSK. Sakamoto J, Koike A, Saji S, Teramukai S, Ohashi Y, Nakazato H. Surg Today; 1992 Apr 01; 22(6):530-6. PubMed ID: 1472793 [Abstract] [Full Text] [Related]
8. [Study on factors influencing survival in patients with advanced gastric carcinoma after resection by Cox's proportional hazard model]. Wang S, Sun Z, Wang S. Zhonghua Zhong Liu Za Zhi; 1996 Nov 01; 18(6):433-5. PubMed ID: 9387295 [Abstract] [Full Text] [Related]
11. Adenocarcinoma in the middle third of the stomach--an evaluation for the prognostic significance of clinicopathological features. Sheen-Chen SM, Chou CW, Chen MC, Chen FC, Chen YS, Chen JJ. Hepatogastroenterology; 1997 Nov 01; 44(17):1488-94. PubMed ID: 9356878 [Abstract] [Full Text] [Related]
13. Serum immunosuppressive acidic protein doubling time as a prognostic factor for recurrent renal cell carcinoma after nephrectomy. Araki K, Igarashi T, Tobe T, Mizoguchi K, Suzuki H, Furuya Y, Ichikawa T, Nakatsu HO, Ito H. Urology; 2006 Dec 01; 68(6):1178-82. PubMed ID: 17141843 [Abstract] [Full Text] [Related]
14. Disseminated tumor cells in the blood of patients with gastric cancer are an independent predictive marker of poor prognosis. Illert B, Fein M, Otto C, Cording F, Stehle D, Thiede A, Timmermann W. Scand J Gastroenterol; 2005 Jul 01; 40(7):843-9. PubMed ID: 16109661 [Abstract] [Full Text] [Related]
15. [Study on serum levels of immunosuppressive acidic protein (IAP) as a marker of renal cell carcinoma]. Hoshino M, Fuji K, Kataoka K, Inoue K, Higaki Y, Imamura K. Hinyokika Kiyo; 1989 Oct 01; 35(10):1647-52. PubMed ID: 2610170 [Abstract] [Full Text] [Related]
16. The clinical significance of p53 accumulation in gastric carcinoma. Starzynska T, Markiewski M, Domagala W, Marlicz K, Mietkiewski J, Roberts SA, Stern PL. Cancer; 1996 May 15; 77(10):2005-12. PubMed ID: 8640663 [Abstract] [Full Text] [Related]
17. The significance of perineural invasion as a prognostic factor in patients with gastric carcinoma. Duraker N, Sişman S, Can G. Surg Today; 2003 May 15; 33(2):95-100. PubMed ID: 12616368 [Abstract] [Full Text] [Related]
18. Preoperative plasma level of IL-10 but not of proinflammatory cytokines is an independent prognostic factor in patients with gastric cancer. Szaflarska A, Szczepanik A, Siedlar M, Czupryna A, Sierzega M, Popiela T, Zembala M. Anticancer Res; 2009 Dec 15; 29(12):5005-12. PubMed ID: 20044609 [Abstract] [Full Text] [Related]
19. Prognostic value of intratumoral natural killer cells in gastric carcinoma. Ishigami S, Natsugoe S, Tokuda K, Nakajo A, Che X, Iwashige H, Aridome K, Hokita S, Aikou T. Cancer; 2000 Feb 01; 88(3):577-83. PubMed ID: 10649250 [Abstract] [Full Text] [Related]